Cancer Genomics and Precision Medicine

Specific PHGKB|Cancer|PHGKB

Cancer Genomics

- Cancer PHGKB -

What's New

Last Posted: Nov 30, 2018

---

• Genomics of response to immune checkpoint therapies for cancer: implications for precision medicine  
  JR Conway et al, Genome Medicine, November 30, 2018
• [Making better use of the clinical geneticist's expertise; treating physician could request a DNA test for most cancer patients].  
  Aalfs C M et al. Nederlands tijdschrift voor geneeskunde 2017 161(0) D1525
• A 3q gene signature associated with triple negative breast cancer organ specific metastasis and response to neoadjuvant chemotherapy.  
  Qian Jun et al. Scientific reports 2017 745828
• A Case-control Study Supporting the Use of Liquid Biopsy in the Targeted Therapy for Lung Cancer  
  Dai Li-Jun et al. Asian Pacific journal of cancer prevention : APJCP 2018 Jul 19(7) 1761-1766
• Circulating tumour DNA sequence analysis as an alternative to multiple myeloma bone marrow aspirates.  
  Kis Olena et al. Nature communications 2017 815086
• Clinical Impact of Single Nucleotide Polymorphism in PD-L1 on Response to Nivolumab for Advanced Non-Small-Cell Lung Cancer Patients.  
  Nomizo Takashi et al. Scientific reports 2017 745124
• EGFR monoclonal antibody biomarkers in advanced NSCLC: from translational research to clinical implementation.  
  Pirker Robert et al. The Lancet. Oncology 2018 19(1) 10-12
• Hereditary diffuse gastric cancer: how to look for and how to manage it.  
  Polom Karol et al. Updates in surgery 2018 Jun 70(2) 161-166
• Liquid Biopsy in Endometrial Cancer: New Opportunities for Personalized Oncology.  
  Muinelo-Romay Laura et al. International journal of molecular sciences 2018 Aug 19(8)
• Molecular diagnostic testing of diffuse gliomas in the real-life setting: A practical approach.  
  Bienkowski Michal et al. Clinical neuropathology 37(4) 166-177